Your browser doesn't support javascript.
loading
A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
Wu, Chiao-Chieh; Liu, Shih-Jen; Chen, Hsin-Wei; Shen, Kuan-Yin; Leng, Chih-Hsiang.
Afiliação
  • Wu CC; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.
  • Liu SJ; National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Miaoli County 350, Taiwan.
  • Chen HW; National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Miaoli County 350, Taiwan.
  • Shen KY; Graduate Institute of Immunology, China Medical University, Taichung 40402, Taiwan.
  • Leng CH; National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Miaoli County 350, Taiwan.
Oncotarget ; 7(21): 30804-19, 2016 May 24.
Article em En | MEDLINE | ID: mdl-27127171
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Linfócitos T Citotóxicos / Leucemia Experimental / Ovalbumina / Apresentação de Antígeno / Vacinas Anticâncer / Receptor 2 Toll-Like Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Linfócitos T Citotóxicos / Leucemia Experimental / Ovalbumina / Apresentação de Antígeno / Vacinas Anticâncer / Receptor 2 Toll-Like Idioma: En Ano de publicação: 2016 Tipo de documento: Article